The virus-like particle chikungunya vaccine received accelerated approval from the FDA in February, and is one of two single-dose vaccines to prevent disease caused by the chikungunya virus.

Virus-like particles (VLPs) are nanoscale particles, approximately 100–300 nm in diameter, formed by self-assembly of viral capsid proteins, which lack viral genetic material, cannot replicate ...

CINCINNATI, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational ...

At present, there are no approved antiviral drugs for Nipah and supportive care is the only option for human infections.

Researchers at CIDR, led by Yuntao Wu, professor in George Mason's School of Systems Biology and the principal investigator of the study, developed a special HIV-like virus particle, called HIV ...

A new study shows virus-like particle can effectively 'shock and kill' latent HIV reservoir in those living with chronic HIV. Skip to main content. Your source for the latest research news.

Pepper the cat, whose owner works at the University of Florida, gathered a specimen containing a never-before-seen virus for ...

May 30, 2023: Artificial virus-like particle could be harnessed to improve human health (Nanowerk News) International researchers have built artificial virus-like particles capable of entering human ...

Touching Base is the dynamic podcast series from the editors of GEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex ...

The virus-like particle technology will be engineered and functionalized for the specific carcinoma cell type using therapeutically validated AAVs, including a novel primer compound. Hovione will be ...